Dow Down 0.05% Nasdaq Up 0.65%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
1.82 Down 0.03(1.63%) 1:06PM EST - Nasdaq Real Time Price
Prev Close:1.85
Open:1.85
Bid:1.80 x 200
Ask:1.82 x 100
1y Target Est:10.17
Beta:2.01
Next Earnings Date:N/A
Day's Range:1.78 - 1.85
52wk Range:1.64 - 6.84
Volume:143,329
Avg Vol (3m):492,202
Market Cap:38.46M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIDown 1.63%38.46M
AGNUp 1.01%62.92B
ALNYUp 5.16%7.42B
MRNA 0.00%23.13M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):454.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.90
Quarterly EPS Est (Dec-14) :-0.19
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback